Hvad er Org-nummeret på IMMUNOPHARMA AS?

IMMUNOPHARMA AS er registreret hos Brønnøysundsregistrene under Org 994924273.

Hvad er omsætningen for IMMUNOPHARMA AS?

IMMUNOPHARMA AS rapporterede en omsætning på NOK 12,2B i 2024.

IMMUNOPHARMA AS beskæftiger 16 personer pr. seneste årsrapport.

Knut Christian Espeseth er administrerende direktør i IMMUNOPHARMA AS, i rollen siden 2024.

Kjetil Ramsøy er bestyrelsesformand i IMMUNOPHARMA AS, i rollen siden 2021.

IMMUNOPHARMA ASs registrerede adresse er Mustads Vei 1A, 0283 Oslo.

ASActive

Org 994924273Mustads Vei 1A, 0283 OsloActivities of advertising agencies· NACE 7311Est. 2010 · 16 years old16 employeeswww.immunopharma.net

Aktivt ansatte i selskabet

Name	Role	Member since
Current (2)
KC Knut Christian Espeseth Chief Executive Officer	Chief Executive Officer	2024
PJ Piotr Jerzy Sierdzinski Deputy Member	Deputy Member	2026
Former (2)
RS Ralf Schmidt Chief Executive Officer	Chief Executive Officer	2021 – 2022
GH Geir Hetland Deputy Member	Deputy Member	2020 – 2021

Ikke-udøvende tilsyn

Name	Role	Member since
Current (3)
FM Frode Marc Bohan Board of Directors	Board of Directors	2021
KØ Kim Øien Board of Directors	Board of Directors	2021
KR Kjetil Ramsøy Chairman	Chairman	2021
Former (1)
KZ Katarzyna Zdzislawa Maresz Board of Directors	Board of Directors	2020 – 2021

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
Bohan & Co As	Company	35.45%	35.45%	2025
Nicoline Invest As	Company	28.9%	28.9%	2025
Equity Labs Sp. Z.O.O Ska	Company	5.91%	5.91%	2025
Six Sis Ag	Company	5.3%	5.3%	2025
Ubs Switzerland Ag	Company	3.72%	3.72%	2025
Nordic Healthy Living As	Company	1.93%	1.93%	2025
Pro As	Company	1.6%	1.6%	2025
Theo Investments As	Company	1.55%	1.55%	2025
Noxa As	Company	1.44%	1.44%	2025
Vestmark Research Consulting As	Company	1.44%	1.44%	2025
3lp Norge As	Company	1.24%	1.24%	2025
Rhumb Line As	Company	1.22%	1.22%	2025
Avanza Bank Ab	Company	1.02%	1.02%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.